Accelerated Clinical Trial Agreement Template for England and Wales

When you need to conduct clinical trials under urgent circumstances, an Accelerated Clinical Trial Agreement provides the legal framework to expedite research while maintaining regulatory compliance under England and Wales law. This specialized contract enables faster trial timelines during public health emergencies or when addressing urgent medical needs, establishing clear obligations between sponsors, clinical research organizations, research institutions, and principal investigators.

When do you need this document?

You require an Accelerated Clinical Trial Agreement when conducting expedited clinical research in response to health emergencies, such as pandemic situations or when testing treatments for rare diseases with limited time windows. This agreement is essential when you need to compress traditional trial timelines while maintaining patient safety standards. You'll also need this document when multiple parties must coordinate rapidly, including pharmaceutical sponsors, contract research organizations, NHS trusts, and academic institutions. The agreement becomes critical when standard trial protocols must be adapted for accelerated recruitment, streamlined data collection, and expedited regulatory submissions to the MHRA.

Key legal considerations

Your agreement must address accelerated patient recruitment procedures while ensuring informed consent processes remain robust and compliant with Good Clinical Practice guidelines. You need to establish clear data ownership and sharing protocols between parties, particularly when multiple organizations contribute resources under compressed timelines. The contract should specify liability allocation and insurance coverage for accelerated trials, as expedited processes may increase certain risks. You must include provisions for rapid safety reporting and adverse event management, ensuring compliance with pharmacovigilance requirements. The agreement should also address intellectual property rights and publication arrangements, particularly important when multiple parties contribute to accelerated research efforts.

Legal requirements in England and Wales

Your Accelerated Clinical Trial Agreement must comply with MHRA regulations governing clinical trial authorization, including specific requirements for expedited review processes during public health emergencies. You need to ensure compliance with the Medicines for Human Use (Clinical Trials) Regulations 2004 and subsequent UK Clinical Trials Regulations, which outline mandatory procedures for trial conduct and monitoring. The agreement must incorporate Data Protection Act 2018 requirements for processing participant health data, including specific provisions for data sharing between parties. You must also ensure compliance with Human Medicines Regulations 2012 regarding investigational medicinal products and their handling. The contract should reference appropriate NHS research governance frameworks and ensure all parties maintain required clinical trial insurance coverage under UK law.